INTRACRANIAL ANEURYSMS (IAS) ARE PATHOLOGICAL DILATATIONS OF THE CEREBRAL ARTERIAL WALL, AFFECTING 2-3% OF THE ADULT POPULATION. THEIR RUPTURE LEADS TO SUBARACHNOID HEMORRHAGE, A DEVASTATING CONDITION ASSOCIATED WITH HIGH MORBIDITY AND MORTALITY. FLOW DIVERTERS (FD) HAVE CHANGED ANEURYSM TREATMENT BY RECONSTRUCTING THE PARENT ARTERY AND PROMOTING ANEURYSM EXCLUSION THROUGH PROGRESSIVE ENDOTHELIALIZATION. HOWEVER, FD THERAPY HAS LIMITATIONS, INCLUDING THROMBOEMBOLIC EVENTS, INCOMPLETE ANEURYSM OCCLUSION IN UP TO 20% OF CASES, AND RISK OF OCCLUSION OF COVERED SIDE BRANCHES. STATINS, HAVE PLEIOTROPIC VASCULAR EFFECTS THAT CAN OPTIMIZE THE FD HEALING. IN ADDITION TO CHOLESTEROL LOWERING EFFECT, STATINS ENHANCE NITRIC OXIDE (NO) BIOAVAILABILITY, MOBILIZES ENDOTHELIAL PROGENITOR CELLS (EPCS), REDUCES INFLAMMATION, AND IMPROVES ENDOTHELIAL REPAIR. THESE MECHANISMS COULD PROMOTE FD STRUTS ENDOTHELIALIZATION, LEADING TO FASTER AND COMPLETE ANEURYSM OCCLUSION WITH HIGHER SIDE BRANCH PATENCY. THIS THESIS INVESTIGATED THE EFFECT OF ROSUVASTATIN ON FD HEALING IN A PRECLINICAL RABBIT MODEL. ELASTASE-INDUCED ANEURYSMS WERE CREATED IN THE RIGHT COMMON CAROTID ARTERY OF 22 RABBITS. FOUR WEEKS LATER IN EACH RABBIT, FDS WERE IMPLANTED IN THE SUBCLAVIAN ARTERY, COVERING THE ELASTASE-INDUCED ANEURYSM (EFFICACY ASSESSMENT), AND IN THE DESCENDING AORTA, COVERING THE LUMBAR BRANCHES (ASSESSMENT OF COVERED BRANCHES PATENCY). RABBITS WERE RANDOMIZED TO RECEIVE EITHER ROSUVASTATIN PLUS ASPIRIN (ROSU+ASA, N=13) OR ASPIRIN ALONE (ASA, N=9). AFTER TWO WEEKS, ANEURYSM OCCLUSION WAS ASSESSED ANGIOGRAPHICALLY WITH THE O’KELLY-MAROTTA (OKM) SCALE, SIDE BRANCHES PATENCY WITH HIGH-FREQUENCY OPTICAL COHERENCE TOMOGRAPHY (HF- OCT), AND STRUTS COVERAGE WITH HISTOLOGY AND MULTIPHOTON MICROSCOPY (MPM). SERUM ROSUVASTATIN CONCENTRATION WAS CORRELATED WITH ENDOTHELIALIZATION. RESULTS SHOWED A TREND TOWARD HIGHER COMPLETE ANEURYSM OCCLUSION IN THE ROSU+ASA GROUP (84.6% VS 66.6%). SIDE BRANCH PATENCY WAS SIGNIFICANTLY IMPROVED, BOTH FOR VESSELS ≥1 MM (94.4% VS 46.1%, P=0.007) AND <1 MM (95.4% VS 73.4%, P=0.036). THE COMPOSITE OUTCOME (COMPLETE OCCLUSION WITH ALL BRANCHES PATENT) FAVORED ROSUVASTATIN (76.9% VS 22.2%, P=0.011). HISTOLOGY DEMONSTRATED A TENDENCY TOWARD INCREASED STRUT COVERAGE AND NEOINTIMAL THICKNESS WITH ROSU+ASA, AND THE AMOUNT OF ENDOTHELIAL COVERING STENT STRUT (ASSESSED WITH THE MPM) HAD A STRONG POSITIVE CORRELATION WITH THE ROSUVASTATIN SERUM LEVELS (R=0.92, P=0.02). IN CONCLUSION, IN THIS ELASTASE-INDUCED ANEURYSM MODEL ROSUVASTATIN THERAPY ENHANCED FD TREATMENT BY PROMOTING ANEURYSM OCCLUSION, PRESERVING SIDE BRANCH PATENCY, AND SUPPORTING ENDOTHELIALIZATION. THESE FINDINGS SUPPORT THE HYPOTHESIS THAT ROSUVASTATIN MAY ENHANCES FLOW DIVERSION EFFICACY AND SAFETY, NEEDING FURTHER PRECLINICAL VALIDATION AND POTENTIAL CLINICAL TRIALS.

ROSUVASTATIN FOR INTRACRANIAL ANEURYSMS TREATED WITH FLOW DIVERTER: PRECLINICAL STUDY IN RABBITS / Francesco Diana , 2025 Dec 18. 37. ciclo, Anno Accademico 2023/24.

ROSUVASTATIN FOR INTRACRANIAL ANEURYSMS TREATED WITH FLOW DIVERTER: PRECLINICAL STUDY IN RABBITS

Diana, Francesco
2025

Abstract

INTRACRANIAL ANEURYSMS (IAS) ARE PATHOLOGICAL DILATATIONS OF THE CEREBRAL ARTERIAL WALL, AFFECTING 2-3% OF THE ADULT POPULATION. THEIR RUPTURE LEADS TO SUBARACHNOID HEMORRHAGE, A DEVASTATING CONDITION ASSOCIATED WITH HIGH MORBIDITY AND MORTALITY. FLOW DIVERTERS (FD) HAVE CHANGED ANEURYSM TREATMENT BY RECONSTRUCTING THE PARENT ARTERY AND PROMOTING ANEURYSM EXCLUSION THROUGH PROGRESSIVE ENDOTHELIALIZATION. HOWEVER, FD THERAPY HAS LIMITATIONS, INCLUDING THROMBOEMBOLIC EVENTS, INCOMPLETE ANEURYSM OCCLUSION IN UP TO 20% OF CASES, AND RISK OF OCCLUSION OF COVERED SIDE BRANCHES. STATINS, HAVE PLEIOTROPIC VASCULAR EFFECTS THAT CAN OPTIMIZE THE FD HEALING. IN ADDITION TO CHOLESTEROL LOWERING EFFECT, STATINS ENHANCE NITRIC OXIDE (NO) BIOAVAILABILITY, MOBILIZES ENDOTHELIAL PROGENITOR CELLS (EPCS), REDUCES INFLAMMATION, AND IMPROVES ENDOTHELIAL REPAIR. THESE MECHANISMS COULD PROMOTE FD STRUTS ENDOTHELIALIZATION, LEADING TO FASTER AND COMPLETE ANEURYSM OCCLUSION WITH HIGHER SIDE BRANCH PATENCY. THIS THESIS INVESTIGATED THE EFFECT OF ROSUVASTATIN ON FD HEALING IN A PRECLINICAL RABBIT MODEL. ELASTASE-INDUCED ANEURYSMS WERE CREATED IN THE RIGHT COMMON CAROTID ARTERY OF 22 RABBITS. FOUR WEEKS LATER IN EACH RABBIT, FDS WERE IMPLANTED IN THE SUBCLAVIAN ARTERY, COVERING THE ELASTASE-INDUCED ANEURYSM (EFFICACY ASSESSMENT), AND IN THE DESCENDING AORTA, COVERING THE LUMBAR BRANCHES (ASSESSMENT OF COVERED BRANCHES PATENCY). RABBITS WERE RANDOMIZED TO RECEIVE EITHER ROSUVASTATIN PLUS ASPIRIN (ROSU+ASA, N=13) OR ASPIRIN ALONE (ASA, N=9). AFTER TWO WEEKS, ANEURYSM OCCLUSION WAS ASSESSED ANGIOGRAPHICALLY WITH THE O’KELLY-MAROTTA (OKM) SCALE, SIDE BRANCHES PATENCY WITH HIGH-FREQUENCY OPTICAL COHERENCE TOMOGRAPHY (HF- OCT), AND STRUTS COVERAGE WITH HISTOLOGY AND MULTIPHOTON MICROSCOPY (MPM). SERUM ROSUVASTATIN CONCENTRATION WAS CORRELATED WITH ENDOTHELIALIZATION. RESULTS SHOWED A TREND TOWARD HIGHER COMPLETE ANEURYSM OCCLUSION IN THE ROSU+ASA GROUP (84.6% VS 66.6%). SIDE BRANCH PATENCY WAS SIGNIFICANTLY IMPROVED, BOTH FOR VESSELS ≥1 MM (94.4% VS 46.1%, P=0.007) AND <1 MM (95.4% VS 73.4%, P=0.036). THE COMPOSITE OUTCOME (COMPLETE OCCLUSION WITH ALL BRANCHES PATENT) FAVORED ROSUVASTATIN (76.9% VS 22.2%, P=0.011). HISTOLOGY DEMONSTRATED A TENDENCY TOWARD INCREASED STRUT COVERAGE AND NEOINTIMAL THICKNESS WITH ROSU+ASA, AND THE AMOUNT OF ENDOTHELIAL COVERING STENT STRUT (ASSESSED WITH THE MPM) HAD A STRONG POSITIVE CORRELATION WITH THE ROSUVASTATIN SERUM LEVELS (R=0.92, P=0.02). IN CONCLUSION, IN THIS ELASTASE-INDUCED ANEURYSM MODEL ROSUVASTATIN THERAPY ENHANCED FD TREATMENT BY PROMOTING ANEURYSM OCCLUSION, PRESERVING SIDE BRANCH PATENCY, AND SUPPORTING ENDOTHELIALIZATION. THESE FINDINGS SUPPORT THE HYPOTHESIS THAT ROSUVASTATIN MAY ENHANCES FLOW DIVERSION EFFICACY AND SAFETY, NEEDING FURTHER PRECLINICAL VALIDATION AND POTENTIAL CLINICAL TRIALS.
18-dic-2025
37
MEDICINA TRASLAZIONALE DELLO SVILUPPO E DELL'INVECCHIAMENTO ATTIVO
ANEURYSM; FLOW DIVERTER; ROSUVASTATIN; ENDOTHELIALIZATION
DI SALLE, Francesco
File in questo prodotto:
File Dimensione Formato  
PhD thesis_abstract.pdf

accesso aperto

Descrizione: Rosuvastatin for intracranial aneurysms treated with flow diverter: preclinical study in rabbits
Tipologia: Tesi di dottorato
Dimensione 98.65 kB
Formato Adobe PDF
98.65 kB Adobe PDF Visualizza/Apri
PhD thesis_FD_Cotutelle.pdf

accesso aperto

Descrizione: Rosuvastatin for intracranial aneurysms treated with flow diverter: preclinical study in rabbits
Tipologia: Tesi di dottorato
Dimensione 13.65 MB
Formato Adobe PDF
13.65 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11386/4969118
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact